Cargando…

Quantifying tumour heterogeneity with CT

Heterogeneity is a key feature of malignancy associated with adverse tumour biology. Quantifying heterogeneity could provide a useful non-invasive imaging biomarker. Heterogeneity on computed tomography (CT) can be quantified using texture analysis which extracts spatial information from CT images (...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganeshan, Balaji, Miles, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613789/
https://www.ncbi.nlm.nih.gov/pubmed/23545171
http://dx.doi.org/10.1102/1470-7330.2013.0015
_version_ 1782264779450089472
author Ganeshan, Balaji
Miles, Kenneth A.
author_facet Ganeshan, Balaji
Miles, Kenneth A.
author_sort Ganeshan, Balaji
collection PubMed
description Heterogeneity is a key feature of malignancy associated with adverse tumour biology. Quantifying heterogeneity could provide a useful non-invasive imaging biomarker. Heterogeneity on computed tomography (CT) can be quantified using texture analysis which extracts spatial information from CT images (unenhanced, contrast-enhanced and derived images such as CT perfusion) that may not be perceptible to the naked eye. The main components of texture analysis can be categorized into image transformation and quantification. Image transformation filters the conventional image into its basic components (spatial, frequency, etc.) to produce derived subimages. Texture quantification techniques include structural-, model- (fractal dimensions), statistical- and frequency-based methods. The underlying tumour biology that CT texture analysis may reflect includes (but is not limited to) tumour hypoxia and angiogenesis. Emerging studies show that CT texture analysis has the potential to be a useful adjunct in clinical oncologic imaging, providing important information about tumour characterization, prognosis and treatment prediction and response.
format Online
Article
Text
id pubmed-3613789
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher e-Med
record_format MEDLINE/PubMed
spelling pubmed-36137892014-06-13 Quantifying tumour heterogeneity with CT Ganeshan, Balaji Miles, Kenneth A. Cancer Imaging Review Heterogeneity is a key feature of malignancy associated with adverse tumour biology. Quantifying heterogeneity could provide a useful non-invasive imaging biomarker. Heterogeneity on computed tomography (CT) can be quantified using texture analysis which extracts spatial information from CT images (unenhanced, contrast-enhanced and derived images such as CT perfusion) that may not be perceptible to the naked eye. The main components of texture analysis can be categorized into image transformation and quantification. Image transformation filters the conventional image into its basic components (spatial, frequency, etc.) to produce derived subimages. Texture quantification techniques include structural-, model- (fractal dimensions), statistical- and frequency-based methods. The underlying tumour biology that CT texture analysis may reflect includes (but is not limited to) tumour hypoxia and angiogenesis. Emerging studies show that CT texture analysis has the potential to be a useful adjunct in clinical oncologic imaging, providing important information about tumour characterization, prognosis and treatment prediction and response. e-Med 2013-03-26 /pmc/articles/PMC3613789/ /pubmed/23545171 http://dx.doi.org/10.1102/1470-7330.2013.0015 Text en © 2013 International Cancer Imaging Society
spellingShingle Review
Ganeshan, Balaji
Miles, Kenneth A.
Quantifying tumour heterogeneity with CT
title Quantifying tumour heterogeneity with CT
title_full Quantifying tumour heterogeneity with CT
title_fullStr Quantifying tumour heterogeneity with CT
title_full_unstemmed Quantifying tumour heterogeneity with CT
title_short Quantifying tumour heterogeneity with CT
title_sort quantifying tumour heterogeneity with ct
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613789/
https://www.ncbi.nlm.nih.gov/pubmed/23545171
http://dx.doi.org/10.1102/1470-7330.2013.0015
work_keys_str_mv AT ganeshanbalaji quantifyingtumourheterogeneitywithct
AT mileskennetha quantifyingtumourheterogeneitywithct